AEGFX
Price
$58.59
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
CCWSX
Price
$19.67
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
Ad is loading...

AEGFX vs CCWSX

Header iconAEGFX vs CCWSX Comparison
Open Charts AEGFX vs CCWSXBanner chart's image
American Funds Europacific Growth F1
Price$58.59
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Baird Chautauqua International Gr I
Price$19.67
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AEGFX vs CCWSX Comparison Chart
Loading...
VS
AEGFX vs. CCWSX commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEGFX is a Buy and CCWSX is a Buy.

FUNDAMENTALS
Fundamentals
AEGFX pays higher dividends than CCWSX: AEGFX (1.48) vs CCWSX (0.15). AEGFX was incepted earlier than CCWSX: AEGFX (24 years) vs CCWSX (9 years). AEGFX is a more actively managed with annual turnover of: 34.00 vs. CCWSX (12.00). AEGFX has a lower initial minimum investment than CCWSX: AEGFX (250) vs CCWSX (2500). CCWSX annual gain was more profitable for investors over the last year : 27.19 vs. AEGFX (15.97). CCWSX return over 5 years is better than : 62.40 vs. AEGFX (11.59).
AEGFXCCWSXAEGFX / CCWSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years9 years-
Gain YTD8.00916.25349%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets134BN/A-
Annual Yield % from dividends1.480.15986%
Returns for 1 year15.9727.1959%
Returns for 3 years-14.49-0.0531,785%
Returns for 5 years11.5962.4019%
Returns for 10 years27.71N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYB87.330.90
+1.04%
LyondellBasell Industries NV
GOOS9.710.10
+1.04%
Canada Goose Holdings
NVEI33.450.05
+0.15%
Nuvei Corp
AFRI10.37-0.13
-1.24%
Forafric Global PLC
NMTC0.90-0.03
-3.72%
NeuroOne Medical Technologies Corp